Actinium Pharmaceuticals reported $13.78M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Actinium Pharmaceuticals USD 13.78M 5.23M Sep/2025
Amgen USD 8.66B 961M Dec/2025
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 83.87M 21.11M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025